## Overview
Night sweats — clinically termed *sleep hyperhidrosis* (ICD-10: R61) — refer to repeated episodes of excessive perspiration during sleep that are severe enough to soak through nightclothes or bedding. They are distinct from simply feeling warm at night due to a heavy duvet or an overheated bedroom. True night sweats occur regardless of the ambient temperature and often wake the affected person from sleep.
Night sweats are remarkably common. A large primary-care survey found that approximately **41 %** of patients reported experiencing night sweats within the previous month, making it one of the most frequently reported symptoms in general practice (PMID: 12019054) [3]. Despite this high prevalence, the symptom is under-discussed: many patients feel embarrassed or assume it is trivial, yet night sweats can occasionally signal serious underlying disease — including lymphoma, tuberculosis, and endocrine disorders.
People search for information about night sweats for several reasons: the symptom is distressing, it disrupts sleep quality, and it provokes anxiety about whether something dangerous may be happening. This article provides an evidence-based overview of causes, self-care measures, medication options, and — critically — the warning signs that should prompt urgent medical evaluation.
> **Disclaimer:** This article is for educational purposes only and does not replace professional medical advice. If you are experiencing persistent or severe night sweats, consult a qualified healthcare provider.
---
## Common Causes
Night sweats arise when the body's thermoregulatory set-point is disturbed, activating the sympathetic nervous system and eccrine sweat glands during sleep. A systematic review identified more than 40 potential causes, which can be grouped by mechanism and approximate frequency (PMID: 23136325) [1].
### 1. Menopause and Perimenopause (Most Common in Women)
Declining oestrogen levels destabilise the hypothalamic thermoregulatory centre, narrowing the thermoneutral zone. Even small core-temperature fluctuations trigger vasodilation and sweating. Up to **75–85 %** of perimenopausal and postmenopausal women experience vasomotor symptoms, including night sweats (PMID: 15495079) [4]. Symptoms may persist for 7–10 years after menopause onset.
### 2. Infections
- **Acute infections:** Common viral illnesses (influenza, COVID-19, upper-respiratory infections) cause fever-related sweating as the hypothalamic set-point normalises during defervescence.
- **Tuberculosis (TB):** Classic "drenching" night sweats are a hallmark of active pulmonary or extrapulmonary TB. The World Health Organization estimates roughly **10.6 million** new TB cases globally per year, and night sweats remain a key screening symptom [5].
- **HIV/AIDS:** Night sweats are common in acute seroconversion and advanced disease.
- **Endocarditis, osteomyelitis, abscesses:** Subacute bacterial infections can produce low-grade fever and nocturnal diaphoresis.
### 3. Medications
Many commonly prescribed drugs cause night sweats as an adverse effect:
- **Antidepressants** — SSRIs and SNRIs are among the most frequent culprits; up to 20 % of users report sweating.
- **Antipyretics** (paradoxically, as fever breaks).
- **Hormonal agents** — tamoxifen, GnRH agonists, aromatase inhibitors.
- **Hypoglycaemic agents** — insulin and sulfonylureas may cause nocturnal hypoglycaemia with resultant sweating.
- **Others** — corticosteroids, opioids, sildenafil.
A thorough medication review is a critical first step in the diagnostic work-up (PMID: 12643362) [2].
### 4. Anxiety and Stress Disorders
Autonomic hyperarousal in generalised anxiety disorder, panic disorder, and post-traumatic stress disorder can increase sympathetic tone during sleep, triggering sweating. Sleep disturbances are often bidirectional — night sweats worsen sleep quality, which worsens anxiety.
### 5. Endocrine and Metabolic Disorders
- **Hyperthyroidism:** Elevated thyroid hormones raise basal metabolic rate and heat production.
- **Phaeochromocytoma:** Catecholamine-secreting adrenal tumours cause episodic sweating, palpitations, and hypertension.
- **Carcinoid syndrome:** Serotonin-secreting tumours can produce flushing and sweating.
- **Diabetes mellitus:** Nocturnal hypoglycaemia triggers a counter-regulatory catecholamine surge.
### 6. Malignancy
- **Lymphoma:** Night sweats are one of the three "B symptoms" (along with unexplained fever >38 °C and weight loss >10 % in 6 months) used in staging Hodgkin and non-Hodgkin lymphoma (PMID: 17687156) [6].
- **Leukaemia, myeloproliferative disorders, solid tumours** (particularly renal cell carcinoma) may also present with drenching sweats.
### 7. Obstructive Sleep Apnoea (OSA)
OSA is an under-recognised cause of night sweats. Repeated apnoeic episodes trigger sympathetic surges that cause sweating. Treatment of OSA with continuous positive airway pressure (CPAP) has been shown to reduce night sweats (PMID: 23136325) [1].
### 8. Idiopathic Hyperhidrosis
When no identifiable cause is found after thorough evaluation, the diagnosis of primary or idiopathic nocturnal hyperhidrosis may be made.
---
## RED FLAGS
Seek **immediate or urgent medical attention** if night sweats are accompanied by any of the following:
- **Unexplained weight loss** (>5 % of body weight in 1 month or >10 % in 6 months)
- **Persistent or recurrent fever** (>38 °C / 100.4 °F) without an obvious infectious source
- **Palpable, painless lymph node enlargement** that persists for more than 2 weeks
- **Severe or worsening shortness of breath, cough, or haemoptysis** (coughing blood)
- **Chest pain, palpitations, or signs of haemodynamic instability** (dizziness, syncope)
- **Known or suspected exposure to tuberculosis**
- **Night sweats with confusion, altered consciousness, or signs of sepsis** (rapid heart rate, low blood pressure, mottled skin) — **call emergency services (911 / 999 / 112)**
- **Symptoms of severe hypoglycaemia** — tremor, confusion, loss of consciousness in a patient taking insulin or sulfonylureas — **call emergency services immediately**
- **New, unexplained petechiae or easy bruising** (may suggest haematological malignancy or coagulopathy)
---
## Self-Care at Home
For mild or isolated night sweats without red-flag features, the following evidence-based non-pharmacological strategies may help:
### Sleep Environment
- **Lower the bedroom temperature** to 16–18 °C (60–65 °F); this is the range generally recommended by sleep experts for optimal thermoregulation.
- **Use moisture-wicking bedding and sleepwear** made from natural fibres (cotton, bamboo, linen) or purpose-designed technical fabrics.
- **Layer bedding** so covers can be easily removed during the night.
- **Use a fan or air conditioning** to promote convective cooling.
### Lifestyle Modifications
- **Avoid known triggers before bed:** spicy food, alcohol, caffeine, and hot beverages within 2–3 hours of sleep.
- **Maintain a healthy weight:** obesity is associated with increased nocturnal sweating, partly through its association with OSA.
- **Regular physical activity** — moderate exercise (150 minutes per week) has been associated with reduced vasomotor symptoms in menopausal women, though evidence is mixed (PMID: 25400224) [7].
- **Stress reduction:** cognitive-behavioural therapy (CBT), mindfulness-based stress reduction, and relaxation techniques have shown benefit for both anxiety-related and menopausal night sweats.
### Hydration
- **Drink adequate water** throughout the day. Keep water by the bedside. Significant nocturnal sweating can contribute to mild dehydration.
### Cool-down Techniques
- A **cool shower** or **lukewarm bath** 1–2 hours before bed may help lower core body temperature via the "warm-bath effect," promoting faster sleep onset and potentially reducing sweating episodes.
- **Cooling pillows or gel pads** placed under the pillowcase may provide symptomatic relief, though controlled-trial evidence is limited.
---
## OTC Medications That Help
Over-the-counter options for night sweats are limited and address specific causes or provide symptomatic relief. Always read labels and consult a pharmacist if you take other medications.
| Class | Example | Typical Adult Dose | Notes |
|---|---|---|---|
| **Phytoestrogens (isoflavones)** | Soy isoflavone supplements | 40–80 mg/day | May modestly reduce menopausal vasomotor symptoms. Evidence is inconsistent; a Cochrane review found limited benefit (PMID: 23440783) [8]. Avoid in oestrogen-receptor-positive breast cancer without medical advice. |
| **Black cohosh** (*Actaea racemosa*) | Remifemin® | 20–40 mg standardised extract twice daily | Some evidence for mild vasomotor symptom relief. Rare hepatotoxicity reported — discontinue if signs of liver injury occur. Not recommended for >6 months without medical review. |
| **Antipyretics** | Paracetamol (acetaminophen), ibuprofen | Paracetamol 500–1000 mg every 4–6 h (max 4 g/day); Ibuprofen 200–400 mg every 4–6 h (max 1200 mg/day OTC) | Appropriate only when night sweats are due to fever from an acute, self-limiting illness. Ibuprofen: avoid in renal impairment, peptic ulcer, or aspirin-sensitive asthma. Paracetamol: avoid in liver disease; do not exceed maximum daily dose. |
| **Antihistamines (sedating)** | Diphenhydramine | 25–50 mg at bedtime | Does not treat the sweating itself but may improve sleep continuity disrupted by sweating. Use short-term only. Avoid in elderly (anticholinergic burden), glaucoma, or prostatic hypertrophy. |
| **Magnesium supplements** | Magnesium glycinate | 200–400 mg at bedtime | May support sleep quality; limited direct evidence for night sweats. Generally well tolerated; may cause loose stools at higher doses. |
> **Important:** OTC medications do not address the underlying cause of night sweats. If sweats are persistent, recurrent, or accompanied by other symptoms, medical evaluation is essential.
---
## Prescription Options
Prescription therapy is typically directed at the underlying cause. When menopause, malignancy-related sweats, or idiopathic hyperhidrosis is the primary driver, the following drug classes may be considered.
| Class | Example(s) | Indication | Notes |
|---|---|---|---|
| **Hormone replacement therapy (HRT)** | Oestradiol (oral, transdermal patch, gel); combined oestrogen–progestogen | Menopausal vasomotor symptoms | Most effective treatment for menopausal night sweats. Reduces symptom frequency by ~75 % (PMID: 15495079) [4]. Prescribe at the lowest effective dose for the shortest duration. Contraindicated in history of breast cancer, VTE, or active liver disease. Prescribed by GPs, gynaecologists, or menopause specialists. |
| **SSRIs / SNRIs (low-dose)** | Paroxetine 7.5 mg (Brisdelle®), venlafaxine 37.5–75 mg | Menopausal vasomotor symptoms (off-label for venlafaxine; FDA-approved for paroxetine 7.5 mg) | Paroxetine 7.5 mg is the only non-hormonal FDA-approved treatment for menopausal hot flushes/night sweats. Venlafaxine and escitalopram also show efficacy. Avoid paroxetine in patients on tamoxifen (CYP2D6 inhibition). |
| **Gabapentin / Pregabalin** | Gabapentin 300 mg at bedtime (up to 900 mg/day) | Vasomotor symptoms; off-label | Moderate efficacy for night sweats; also aids sleep. Drowsiness is a common side effect but may be beneficial at bedtime. Dose adjustment required in renal impairment. |
| **Clonidine** | Clonidine 25–75 µg twice daily | Menopausal vasomotor symptoms; off-label | Alpha-2 adrenergic agonist that reduces sympathetic outflow. NICE recommends it as a non-hormonal option for menopausal symptoms [9]. Side effects include dry mouth, drowsiness, and hypotension. |
| **Oxybutynin** | Oxybutynin 2.5–5 mg at bedtime | Idiopathic hyperhidrosis; off-label | Anticholinergic that reduces sweat gland output. May cause dry mouth, constipation, urinary retention. Avoid in elderly and patients with cognitive impairment. |
| **Fezolinetant** | Fezolinetant 45 mg once daily (Veozah®) | Menopausal vasomotor symptoms (FDA-approved 2023) | NK3 receptor antagonist — a novel non-hormonal mechanism. Contraindicated in hepatic impairment (CYP1A2 substrate). Liver function monitoring recommended. |
| **Anti-TB therapy** | Isoniazid, rifampicin, ethambutol, pyrazinamide | Active tuberculosis | Night sweats from TB resolve with appropriate antimicrobial therapy. Managed by infectious-disease specialists or TB clinics. |
| **Cancer-directed therapy** | Chemotherapy, immunotherapy, radiation | Lymphoma and other malignancies | B-symptom night sweats resolve with successful treatment of the underlying malignancy. Managed by oncology/haematology teams. |
---
## Lab Tests Typically Ordered
When night sweats are persistent, unexplained, or accompanied by other symptoms, a structured laboratory work-up helps narrow the differential diagnosis.
| Test | Rationale |
|---|---|
| **Full blood count (FBC / CBC)** with differential | Screen for leukaemia, lymphoma, infection, anaemia. [More info →](/tests/complete-blood-count) |
| **Erythrocyte sedimentation rate (ESR) and/or C-reactive protein (CRP)** | Non-specific markers of inflammation or infection. Elevated in TB, lymphoma, autoimmune disease. [More info →](/tests/esr) |
| **Thyroid function tests (TSH, free T4)** | Rule out hyperthyroidism as a cause of heat intolerance and sweating. [More info →](/tests/thyroid-function) |
| **Blood glucose / HbA1c** | Assess for diabetes mellitus and risk of nocturnal hypoglycaemia. [More info →](/tests/hba1c) |
| **HIV serology** | HIV testing is recommended in any patient with unexplained night sweats, particularly with risk factors. [More info →](/tests/hiv-test) |
| **Chest X-ray** | Screen for pulmonary TB, lymphoma (mediastinal lymphadenopathy), and lung malignancy. |
| **Lactate dehydrogenase (LDH)** | Elevated in lymphoma and other haematological malignancies. [More info →](/tests/ldh) |
| **Blood cultures** | If endocarditis or occult bacteraemia is suspected. |
| **Tuberculin skin test (Mantoux) / Interferon-gamma release assay (IGRA)** | If TB exposure is suspected. [More info →](/tests/tuberculosis-test) |
| **Peripheral blood film** | If abnormal FBC — look for blast cells (leukaemia) or atypical lymphocytes. |
| **Follicle-stimulating hormone (FSH)** | Confirm menopausal status in women with atypical presentations. [More info →](/tests/fsh) |
| **24-hour urinary catecholamines / metanephrines** | If phaeochromocytoma is suspected (episodic sweating, hypertension, palpitations). |
Additional imaging (CT, PET-CT) or tissue biopsy may be required based on initial findings.
---
## Special Populations
### Children and Adolescents
Night sweats are relatively common in children and are usually benign — often related to overheating, viral illnesses, or nightmares. However, persistent night sweats in a child should be evaluated to exclude:
- **Infections** — particularly TB in endemic regions or after known exposure.
- **Lymphoma** — night sweats with lymphadenopathy, unexplained weight loss, or fatigue warrant urgent paediatric referral.
- **Obstructive sleep apnoea** — common in children with adenotonsillar hypertrophy.
> **Note:** Do not administer OTC medications for night sweats to children without consulting a paediatrician. Paediatric dosing for antipyretics should follow weight-based guidelines per the relevant national formulary.
### Pregnancy
- Night sweats are common in pregnancy and the postpartum period due to hormonal fluctuations and increased basal metabolic rate.
- **HRT is contraindicated** during pregnancy.
- **SSRIs:** Paroxetine is generally avoided in pregnancy (former FDA Category D — associated with cardiac malformations in first trimester). Sertraline is often preferred when an SSRI is needed.
- **Non-pharmacological measures** (sleep environment, hydration, loose clothing) are first-line.
- Persistent or severe postpartum night sweats beyond 6 weeks should be evaluated (thyroid function, infection).
### Elderly
- **Polypharmacy** is the most common reversible cause of night sweats in older adults. A systematic medication review is essential.
- **Anticholinergic medications** (oxybutynin, diphenhydramine) should generally be avoided in the elderly due to increased risk of confusion, falls, and cognitive impairment — consistent with the Beers Criteria.
- **TB and malignancy** should remain high on the differential in older adults with unexplained night sweats and weight loss.
- **HRT in women over 60** or more than 10 years post-menopause carries increased cardiovascular and thromboembolic risk and is generally not recommended for new initiation solely for vasomotor symptoms.
### Athletes
- Athletes may experience night sweats related to intense training — elevated metabolic rate, altered thermoregulation, and post-exercise thermogenesis.
- **Over-training syndrome** can present with disturbed sleep, night sweats, and reduced performance.
- Adequate rehydration with electrolyte-containing fluids is important.
- **Relative energy deficiency in sport (RED-S)** with hormonal disturbances can contribute to thermoregulatory dysfunction.
- Rule out supplement- or performance-enhancing-substance-related causes.
---
## When to Escalate
Use the following thresholds to determine the appropriate level of medical care:
### Self-Care at Home (No Immediate Medical Visit Needed)
- Isolated night sweats during an obvious acute viral illness (cold, flu) that is improving.
- Night sweats clearly linked to a warm sleeping environment that resolve with cooling measures.
- Infrequent, mild episodes without any other symptoms.
### Book a GP / Primary-Care Appointment (Within 1–2 Weeks)
- Night sweats occurring **3 or more nights per week** for more than **2 weeks** without an obvious cause.
- Night sweats that began after starting a new medication.
- Menopausal symptoms significantly affecting quality of life or sleep.
- Mild fatigue, low-grade joint pain, or other non-urgent symptoms accompanying the sweats.
### Same-Day GP or Urgent Care (Within 24 Hours)
- Night sweats with **new lymph node swelling** that has persisted for more than 2 weeks.
- Night sweats with **unexplained weight loss** of more than 5 % in 1 month.
- Night sweats with **persistent low-grade fever** (>37.8 °C / 100 °F) for more than 1 week.
- Night sweats with known **TB contact** or recent travel to a TB-endemic region.
- Night sweats with **symptoms of hyperthyroidism** (tremor, weight loss, tachycardia, heat intolerance).
### Emergency Department / Call 911 (Immediately)
- Night sweats with **high fever (>39 °C / 102.2 °F)**, rigors, and signs of sepsis (confusion, rapid breathing, mottled skin, hypotension).
- Night sweats with **severe chest pain, shortness of breath, or haemoptysis**.
- Night sweats with **signs of severe hypoglycaemia** (loss of consciousness, seizures, inability to take oral glucose).
- Night sweats with **acute confusion, altered consciousness, or neurological deficits**.
---
## References
[1] Mold JW, Holtzclaw BJ, McCarthy L. Night sweats: a systematic review of the literature. *J Am Board Fam Med*. 2012;25(6):878–893. PMID: 23136325.
[2] Viera AJ, Bond MM, Yates SW. Diagnosing night sweats. *Am Fam Physician*. 2003;67(5):1019–1024. PMID: 12643362.
[3] Mold JW, Mathew MK, Belgore S, DeHaven M. Prevalence of night sweats in primary care patients: an OKPRN and TAFP-Net study. *J Fam Pract*. 2002;51(5):452–456. PMID: 12019054.
[4] Maclennan AH, Broadbent JL, Lester S, Moore V. Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. *Cochrane Database Syst Rev*. 2004;(4):CD002978. PMID: 15495079.
[5] World Health Organization. *Global Tuberculosis Report 2023*. Geneva: WHO; 2023. Available at: https://www.who.int/teams/global-tuberculosis-programme/tb-reports.
[6] Gobbi PG, Cavalli C, Gendarini A, et al. Reevaluation of prognostic significance of symptoms in Hodgkin's disease. *Cancer*. 1985;56(12):2874–2880. PMID: 4052958.
[7] Daley A, Stokes-Lampard H, Thomas A, MacArthur C. Exercise for vasomotor menopausal symptoms. *Cochrane Database Syst Rev*. 2014;(11):CD006108. PMID: 25400224.
[8] Lethaby A, Marjoribanks J, Kronenberg F, Roberts H, Eden J, Brown J. Phytoestrogens for menopausal vasomotor symptoms. *Cochrane Database Syst Rev*. 2013;(12):CD001395. PMID: 24323914.
[9] National Institute for Health and Care Excellence (NICE). Menopause: diagnosis and management. NICE guideline [NG23]. Updated December 2019. Available at: https://www.nice.org.uk/guidance/ng23.
[10] U.S. Food and Drug Administration. FDA approves novel drug to treat moderate to severe hot flashes caused by menopause (Veozah/fezolinetant). FDA News Release, May 2023.
---
*Last reviewed: April 2026. This article is reviewed regularly and updated when new evidence becomes available. It does not constitute medical advice — always consult a qualified healthcare professional for diagnosis and treatment.*
PillsCard
Reading from 50+ regulators…
Loading the latest data0%